$134.970
+0.013 (+0.01%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
APGE Prediction & Forecast by Similar Chart Analysis
Alphio's APGE stock price prediction model matches the current Apogee Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $136.47 (+1.11%). The 1-week path is $132.77 (-1.63%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Apogee Therapeutics, Inc. Stock?
Apogee Therapeutics Inc (APGE) is currently trading at $134.97, which is very close to the analyst price target of $135. This indicates that the stock is fairly valued at this moment. The RSI is at 82.663, suggesting that the stock is overbought, which could lead to a price correction. Additionally, the company has reported significant net income losses, with the latest quarter showing a net loss of $85,854,000. The acquisition by AbbVie for $10.9 billion could provide long-term growth potential, but the immediate financial health appears strained due to ongoing losses and high debt obligations. The main risk is the potential dilution of earnings per share by $0.14 as a result of the acquisition financing, which could impact short-term investor sentiment.
APGE stock price ended at $134.97 on Friday, after rising +0.01%
Apogee Therapeutics, Inc. (APGE) last closed at $134.97, gaining +0.01%. These facts feed the 1-day and 1-week APGE price prediction above.
Forecast Drivers
Apogee Therapeutics, Inc. (APGE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches APGE, ranked by similarity.
Seasonality analysis for APGE
Historically the probability of a positive August return for APGE is 66.67%. November offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for APGE
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $27.57 | $36.08 | $40.73 | -73.27% |
| Sep 2026 | $28.73 | $35.08 | $38.50 | -74.01% |
| Oct 2026 | $35.91 | $43.15 | $43.56 | -68.03% |
| Nov 2026 | $26.97 | $35.08 | $38.09 | -74.01% |
| Dec 2026 | $31.96 | $39.91 | $44.90 | -70.43% |
In 2026, Apogee Therapeutics, Inc. (APGE) is projected to range from $26.97 to $44.90.
Apogee Therapeutics, Inc. 2026 monthly forecast
In Aug 2026, Apogee Therapeutics, Inc. is projected to average $36.08, with a low of $27.57 and high of $40.73.
In Sep 2026, Apogee Therapeutics, Inc. is projected to average $35.08, with a low of $28.73 and high of $38.50.
In Oct 2026, Apogee Therapeutics, Inc. is projected to average $43.15, with a low of $35.91 and high of $43.56.
In Nov 2026, Apogee Therapeutics, Inc. is projected to average $35.08, with a low of $26.97 and high of $38.09.
In Dec 2026, Apogee Therapeutics, Inc. is projected to average $39.91, with a low of $31.96 and high of $44.90.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.